888午夜不卡理论久久另类_国产伦子系列沙发午睡_020国产亚洲人成在线视频_精品欧美一区二区三区_国产欧美中文字幕

18611095289

news

公司新聞

當(dāng)前位置:首頁(yè)公司新聞Biomedica 公司NT-proBNP ELISA Kit 簡(jiǎn)介

Biomedica 公司NT-proBNP ELISA Kit 簡(jiǎn)介

更新時(shí)間:2014-03-23點(diǎn)擊次數(shù):1044

NT-proBNP ELISA Kit (Cat.No.SK-1204)

為什么要檢測(cè)NT-proBNP ?

NT-proBNP proBNP分解后的76氨基酸片段。proBNP是心臟為彌補(bǔ)收縮無(wú)力而增大時(shí),心壁被拉伸時(shí)由心臟釋放到血液中的化學(xué)物質(zhì)。一旦從心臟釋放到血液中,proBNP就會(huì)分割為NT-proBNPBNP。由于NT-proBNP的半衰期為120min,相比之下,BNP的半衰期僅20min。所以NT-proBNP可追蹤的時(shí)間可達(dá)24hBNPzui多可監(jiān)測(cè)的時(shí)間為1h。因此,檢測(cè)血清/血漿中的NT-proBNP穩(wěn)定性更好,檢測(cè)結(jié)果更可靠,是有效的心衰檢測(cè)工具。

應(yīng)用領(lǐng)域:

  1. 心臟衰竭、急性心肌梗死(左心室功能不全)
  2. 腎衰竭
  3. 肥胖癥和糖尿病
  4. 各種形式的繼發(fā)性高血壓
  5. 心衰患者的療效監(jiān)測(cè)

產(chǎn)品優(yōu)勢(shì):

  1. 性價(jià)比高
  2. 可用于每個(gè)實(shí)驗(yàn)室或開(kāi)放實(shí)驗(yàn)室
  3. CE 標(biāo)志-可用于臨床診斷
  4. 簡(jiǎn)單-傳統(tǒng)96孔板
  5. 動(dòng)態(tài)檢測(cè)范圍廣-可用于早期心衰檢測(cè)

試劑盒特點(diǎn):

檢測(cè)方法:夾心ELISAHRP/TMB顯色,12x8 板條

樣本類型:血清

樣品量:50ul/test

標(biāo)準(zhǔn)品范圍:0-640 pmol/L

檢測(cè)靈敏度:3pmol/L

孵育條件:3h/30min

單位換算:1pmol/L=8.475pg/ml

參考文獻(xiàn):

1

Infliximab Treatment Increases Left Ventricular Ejection Fraction in Patients with Rheumatoid Arthritis: Assessment of Heart Function by Echocardiography, Endothelin 1, Interleukin 6, and NT-pro Brain Natriuretic Peptide. PRZEMYSLAW J,et al. J Rheumatol, Apr 2012; 39: 701 - 706.

2

Left Ventricular Function Impairment in Patients With Normal-Weight Obesity:

Contribution of Abdominal Fat Deposition, Profibrotic State, Reduced Insulin

Sensitivity, and Proinflammatory Activation. Wojciech Kosmala,et al. Circ Cardiovasc Imaging, May 2012; 5: 349 - 356.

3

Prognostic value of left atrial expansion index and exercise-induced change in atrial natriuretic peptide as long-term predictors of atrial fibrillation recurrence..Malini Govindan,et al. Europace, Sep 2012; 14: 1302 - 1310.

4

Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl

oxidase? Begoña López,et al. Cardiovasc Res, Jul 2013; 99: 111 - 120. 

5

High-sensitivity troponin assay improves prediction of cardiovascular risk in

patients with cerebral ischaemia. Raoul Stahrenberg,et al. J. Neurol. Neurosurg. Psychiatry, May 2013; 84: 479 - 487.

6

Translational phases of evidence in a prognostic biomarker: a systematic review and meta-analysis of natriuretic peptides and the prognosis of stable coronary disease. Shailen Sutaria,et al. Heart, Apr 2012; 98: 615 - 622. 

7

Prognostic impact of body mass index in patients undergoing coronary artery

bypass surgery. Shih-Hsien Sung,et al. Heart, Apr 2011; 97: 648 - 654.

8

Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus

scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants. Afif F EL-Khuffash,et al. Arch. Dis. Child. Fetal Neonatal Ed., Mar 2011; 96: F133 - F137. 

9

Multidimensional assessment of older people with asthma and COPD: clinical

management and health status. Vanessa M. McDonald,et al. Age Ageing, Jan 2011; 40: 42 – 49

10

Diagnostic value of NT-proBNP in identifying aortic stenosis patients with heart failure. C Wu,et al. Zhonghua Xin Xue Guan Bing Za Zhi, Jul 2010; 38(7): 579-83.

11

Pulmonary arterial hypertension in rheumatic mitral stenosis: does it affect right

ventricular function and outcome after mitral valve replacement? Shantanu Pande,et al. Interact CardioVasc Thorac Surg, Sep 2009; 9: 421 - 425

12

Pulmonary arterial hypertension in rheumatic mitral stenosis: does it affect right

ventricular function and outcome after mitral valve replacement? Shantanu Pande,et al. Interactive CardioVascular and Thoracic Surgery, Sep 2009; 9: 421 - 425.

13

Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular

function in patients with symptomatic heart failure. John K. Kjekshus,et al. Eur J Heart Fail, Aug 2009; 11: 771 – 778

14

Prevalence of Left Ventricular Diastolic Dysfunction in a General Population. Tatiana Kuznetsova,et al. Circ Heart Fail, Mar 2009; 2: 105 - 112.

 

服務(wù)熱線
18611095289

掃碼加微信